Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab (AVASTIN ®) in Combination With Weekly Paclitaxel Chemotherapy in First Line Treatment Patients With Metastatic Breast Cancer

NCT01745757 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01745757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01745757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab (AVASTIN ®) in Combination With Weekly Paclitaxel Chemotherapy in First Line Treatment Patients With Metastatic Breast Cancer
Lead sponsor
UNICANCER
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2022
Enrollment
510 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic